Corcept Therapeutics is a commercial-stage pharmaceutical company founded in California that focuses primarily on discovering and developing drugs that modulate cortisol to treat severe endocrinologic, oncologic, metabolic, and neurologic conditions. Over the years, the company advanced its proprietary research to pioneer selective glucocorticoid receptor antagonists, achieving commercial success with its flagship Cushing's syndrome treatment while expanding clinical trials into oncology and metabolic diseases.